187 related articles for article (PubMed ID: 11477645)
21. Proton MRS of large multiple sclerosis lesions reveals subtle changes in metabolite T(1) and area.
Brief EE; Vavasour IM; Laule C; Li DK; Mackay AL
NMR Biomed; 2010 Nov; 23(9):1033-7. PubMed ID: 20963799
[TBL] [Abstract][Full Text] [Related]
22. Fast mapping of the T2 relaxation time of cerebral metabolites using proton echo-planar spectroscopic imaging (PEPSI).
Tsai SY; Posse S; Lin YR; Ko CW; Otazo R; Chung HW; Lin FH
Magn Reson Med; 2007 May; 57(5):859-65. PubMed ID: 17457864
[TBL] [Abstract][Full Text] [Related]
23. Brainstem metabolites in multiple system atrophy of cerebellar type: 3.0-T magnetic resonance spectroscopy study.
Takado Y; Igarashi H; Terajima K; Shimohata T; Ozawa T; Okamoto K; Nishizawa M; Nakada T
Mov Disord; 2011 Jun; 26(7):1297-302. PubMed ID: 21370263
[TBL] [Abstract][Full Text] [Related]
24. Volume correction for edema in single-volume proton MR spectroscopy of contrast-enhancing multiple sclerosis lesions.
Helms G
Magn Reson Med; 2001 Aug; 46(2):256-63. PubMed ID: 11477628
[TBL] [Abstract][Full Text] [Related]
25. Cerebral glucose is detectable by localized proton NMR spectroscopy in normal rat brain in vivo.
Gyngell ML; Michaelis T; Hörstermann D; Bruhn H; Hänicke W; Merboldt KD; Frahm J
Magn Reson Med; 1991 Jun; 19(2):489-95. PubMed ID: 1679190
[TBL] [Abstract][Full Text] [Related]
26. Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T.
Wellard RM; Briellmann RS; Jennings C; Jackson GD
AJNR Am J Neuroradiol; 2005 Mar; 26(3):585-90. PubMed ID: 15760870
[TBL] [Abstract][Full Text] [Related]
27. Double-echo multislice proton spectroscopic imaging using Hadamard slice encoding.
Dreher W; Leibfritz D
Magn Reson Med; 1994 Jun; 31(6):596-600. PubMed ID: 7914661
[TBL] [Abstract][Full Text] [Related]
28. Aging alters the multichemical networking profile of the human brain: an in vivo (1)H-MRS study of young versus middle-aged subjects.
Grachev ID; Swarnkar A; Szeverenyi NM; Ramachandran TS; Apkarian AV
J Neurochem; 2001 Apr; 77(1):292-303. PubMed ID: 11279285
[TBL] [Abstract][Full Text] [Related]
29. Proton MRS in acute traumatic brain injury: role for glutamate/glutamine and choline for outcome prediction.
Shutter L; Tong KA; Holshouser BA
J Neurotrauma; 2004 Dec; 21(12):1693-705. PubMed ID: 15684761
[TBL] [Abstract][Full Text] [Related]
30. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of myo-inositol quantification using LCmodel at 1.5 T and 3.0 T with 3 D 1H proton spectroscopic imaging of the human brain.
Srinivasan R; Vigneron D; Sailasuta N; Hurd R; Nelson S
Magn Reson Imaging; 2004 May; 22(4):523-8. PubMed ID: 15120172
[TBL] [Abstract][Full Text] [Related]
32. Proton MRS in Kennedy disease: absolute metabolite and macromolecular concentrations.
Mader I; Karitzky J; Klose U; Seeger U; Sperfeld A; Naegele T; Schick F; Ludolph A; Grodd W
J Magn Reson Imaging; 2002 Aug; 16(2):160-7. PubMed ID: 12203763
[TBL] [Abstract][Full Text] [Related]
33. Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy.
Ziyeh S; Thiel T; Spreer J; Klisch J; Schumacher M
Epilepsia; 2002 Sep; 43(9):1101-5. PubMed ID: 12199737
[TBL] [Abstract][Full Text] [Related]
34. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
Baruth JM; Wall CA; Patterson MC; Port JD
Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
[TBL] [Abstract][Full Text] [Related]
35. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla.
Schubert F; Gallinat J; Seifert F; Rinneberg H
Neuroimage; 2004 Apr; 21(4):1762-71. PubMed ID: 15050596
[TBL] [Abstract][Full Text] [Related]
36. Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy.
Chang Y; Woo ST; Lee JJ; Song HJ; Lee HJ; Yoo DS; Kim SH; Lee H; Kwon YJ; Ahn HJ; Ahn JH; Park SJ; Weon YC; Chung IS; Jeong KS; Kim Y
Neurotoxicology; 2009 Nov; 30(6):950-7. PubMed ID: 19631686
[TBL] [Abstract][Full Text] [Related]
37. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
[TBL] [Abstract][Full Text] [Related]
38. Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imaging.
Chard DT; McLean MA; Parker GJ; MacManus DG; Miller DH
J Magn Reson Imaging; 2002 Feb; 15(2):219-25. PubMed ID: 11836781
[TBL] [Abstract][Full Text] [Related]
39. Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis.
Atassi N; Xu M; Triantafyllou C; Keil B; Lawson R; Cernasov P; Ratti E; Long CJ; Paganoni S; Murphy A; Salibi N; Seethamraju R; Rosen B; Ratai EM
PLoS One; 2017; 12(5):e0177680. PubMed ID: 28498852
[TBL] [Abstract][Full Text] [Related]
40. Proton T2 relaxation of cerebral metabolites during transient global ischemia in rat brain.
Fujimori H; Michaelis T; Wick M; Frahm J
Magn Reson Med; 1998 Apr; 39(4):647-50. PubMed ID: 9543428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
